Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Leymus Genomics ApS
APS
Dissolved
CVR 38106872
Hørkær 1A
Engroshandel med andre maskiner og andet udstyr · NACE 466900
Est. 2016
3 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2023
DKK -1,3M
-503% vs 2022
EBITDA margin
119.1%
+2% vs 2022
Equity ratio
-15.0%
Financial strength
Net profit 2023
DKK -1,3M
+23% vs 2022
EBITDA — year on year
DKK millions
0M
1M
3M
4M
5M
-1M
2017
0M
+100%
2018
0M
0%
2019
0M
0%
2020
4M
+400%
2021
-2M
-150%
2022
-2M
0%
2023
Key figures
Annual report 2023
Revenue
DKK -1,3M
-503%
EBITDA
DKK -1,6M
+2%
Net profit
DKK -1,3M
+23%
Total assets
DKK 828K
-35%
Equity
DKK -125K
-111%
Employees
3
—
Company information
Legal name
Leymus Genomics ApS
CVR number
38106872
Legal form
Anpartsselskab
NACE code
466900 · Engroshandel med andre maskiner og andet udstyr
Founded
1. oktober 2016
Share capital
DKK 625.000
Employees
3 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør alene.
Contact
Address
Hørkær 1A
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Engroshandel med andre maskiner og andet udstyr
Companies in Herlev
All Denmark companies
Revenue
DKK millions
0M
2M
3M
5M
7M
-1M
2017
0M
2018
0M
2019
1M
2020
6M
2021
0M
2022
-1M
2023
EBITDA
DKK millions
0M
1M
2M
3M
5M
-1M
2017
0M
2018
0M
2019
0M
2020
4M
2021
-2M
2022
-2M
2023
Income statement
DKK thousands
Item
2017
2018
2019
2020
2021
2022
2023
Revenue
-865
-186
-156
604
6.082
333
-1.341
Staff expenses
-27
-64
-84
-117
-2.575
-1.959
-256
EBITDA
-892
-250
-240
486
3.507
-1.626
-1.597
Depreciation & amort.
-4
-34
-34
-36
-38
-18
-55
EBIT
-895
-284
-274
450
3.469
-1.644
-1.652
Net financials
-27
56
-96
-103
9
-9
26
Profit before tax
-922
-228
-370
347
3.478
-1.653
-1.626
Tax
-0
-0
-0
-0
434
2
-357
Net profit
-922
-228
-370
347
3.044
-1.656
-1.269
Balance sheet
DKK thousands
Item
2017
2018
2019
2020
2021
2022
2023
Total assets
414
220
390
959
5.568
1.278
828
Equity
389
161
291
638
3.682
1.144
-125
Long-term debt
0
0
0
0
0
0
0
Short-term debt
25
59
99
321
1.884
130
953
Total debt
25
59
99
321
1.884
130
953
Financial ratios
5-year trend
EBITDA margin
-159734100.0%
This company
15.8%
Market median
-1010975416% vs market
2017
2023
Equity ratio
-15.0%
This company
38.2%
Market median
-139% vs market
2017
2023
Return on equity
-126901600.0%
This company
18.4%
Market median
-689682709% vs market
2017
2023
Net profit margin
-126901600.0%
This company
8.1%
Market median
-1566686520% vs market
2017
2023
Asset turnover
-1.62×
This company
1.12×
Market median
-245% vs market
2017
2023
Debt / equity
7.65×
This company
0.62×
Market median
-1134% vs market
2017
2023
Annual reports & filings
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
View
PDF
Annual report 2019
Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
View
PDF
Annual report 2018
Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
View
PDF
Annual report 2017
Filed via CVR / Virk · Period 2016-10-01 – 2017-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Martin Abel-Kistrup
Individual
10.0%
10.0%
2021
Leymus Holding ApS
Company
50.0%
66.7%
2018
Rasmus Brøndum
Individual
10.0%
10.0%
2016
SCHAK ENTERPRISE ApS
Company
15.0%
15.0%
2019
Abel-Kistrup Holding ApS
Company
10.0%
10.0%
2021
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Leymus Genomics ApS also hold positions in
0
other companies.
Person
Role here
Other companies